Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
DUBLIN, Sept. 2, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chats at the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 1:30 p.m. ET...
Covered in this story
What has happened since
- Wells Fargo is down 8.8% since this was published, 33 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Wells Fargo
- UBS: $81.4 → $102 by Oct 2027 · Buy via marketscreener.com
- Morgan Stanley: $80.5 → $102 by Oct 2027 · Overweight via Investing.com India
- JPMorgan: $80.5 → $91.5 by Oct 2027 · Neutral via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $WFC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Wells Fargo →Dalsna Finance is currently tracking 59 stories mentioning Wells Fargo, the earliest published 27 May 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.